Auckland, New Zealand

Michael John Bickerdike

USPTO Granted Patents = 7 


 

Average Co-Inventor Count = 2.9

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2014-2021

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Michael John Bickerdike: Innovator in Therapeutic Compounds

Introduction

Michael John Bickerdike is a notable inventor based in Auckland, New Zealand. He has made significant contributions to the field of therapeutic compounds, particularly in the treatment of autism and related disorders. With a total of seven patents to his name, Bickerdike's work is focused on developing innovative solutions for complex medical conditions.

Latest Patents

Bickerdike's latest patents include groundbreaking inventions related to bicyclic compounds and their therapeutic applications. One of his patents details compositions and methods for the use of diketopiperazines, including cyclic G-2-Allyl Proline and other cyclic Glycyl Proline compounds, aimed at treating symptoms of Autistic Disorder or Autism. This invention encompasses the manufacture of various medicaments, such as tablets, capsules, liquid formulations, gels, and injectable solutions, which are beneficial for treating these conditions. Another patent expands on this concept, focusing on the use of these compounds for treating Autism Spectrum Disorders and Neurodevelopmental Disorders, further emphasizing the versatility and potential impact of his work.

Career Highlights

Bickerdike is associated with Neuren Pharmaceuticals Limited, where he continues to advance his research and development efforts. His career is marked by a commitment to improving therapeutic options for individuals affected by autism and related disorders. His innovative approach has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Throughout his career, Bickerdike has collaborated with esteemed colleagues, including Michael Frederick Snape and Lawrence Irwin Glass. These partnerships have fostered a collaborative environment that enhances the development of effective therapeutic solutions.

Conclusion

Michael John Bickerdike's contributions to the field of therapeutic compounds are noteworthy and impactful. His innovative patents and dedication to improving treatment options for autism and related disorders highlight his importance as an inventor. Bickerdike's work continues to inspire advancements in medical research and therapeutic development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…